Notification letter and reply form to registered shareholders - notice of publication of 2026 interim report
Filed with HKEX · Stock code 2348 · · 2 pages · English and Chinese
The English and Chinese versions of the Company’s Current Corporate Communication are now available on the Company’s website at www.dawnrays.com and the website of The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) at www.hkexnews.hk respectively (the “Website Version”). The Company strongly recommends you to access the Website Version of the Current Corporate Communication and all fut
Dawnrays Pharmaceutical Holdings Ltd. on 6ix
Earlier from Dawnrays Pharmaceutical
- 2026 Interim report
- Discloseable transaction - investment in a limited partnership
- Dawnrays Pharmaceutical Holdings: Proposals for general mandates to issue and repurchase shares; re-election of directors and notice of annual general meeting
- Next Day Disclosure Return
- Dawnrays Pharmaceutical Holdings: Supplemental announcement in relation to 2019 annual report
Later from Dawnrays Pharmaceutical
- Notification letter and request form to non-registered holder - notice of publication of 2026 interim report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- (Revised) Next Day Disclosure Return
Follow Dawnrays Pharmaceutical into a list and get an email when it puts out news.
Follow Dawnrays Pharmaceutical